Both in Biotechnology
Senti Biosciences Holdings vs Scilex Holding
Over the past year SNTI returned −91.4% and SCLX returned −91.8%; their daily moves had a correlation of 0.11.
SNTI −91.4% SCLX −91.8%Growth of $1, one year, split-adjusted
| Metric | SNTI | SCLX |
|---|---|---|
| Price | $0.1553 | $1.61 |
| Market cap | $6.0M | $11.3M |
| Today | −12.06% | −12.02% |
| 1 month | −52.9% | −53.9% |
| 6 months | −84.2% | −80.0% |
| Year to date | −85.1% | −86.8% |
| 1 year | −91.4% | −91.8% |
| Revenue growth (YoY) | — | −22.8% |
| Gross margin | 100.0% | 51.9% |
| Net margin | −75000.0% | −1501.3% |
| P/E (TTM) | — | — |
| Price / sales | 108.6× | 0.4× |
| Net cash | $2.5M | -$82.5M |
| Dividend yield | — | — |
| Volatility (60d) | 117.1% | 72.6% |
| Short % of float | 4.1% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).